More articles from Epigenetics

ARID1A-Mutated Cancers Are Sensitive to EZH2 Methyltransferase Inhibition
Cancer Discovery Apr 2015, 5 (4) OF6; DOI: 10.1158/2159-8290.CD-RW2015-034
The Transcription Factor WT1 Regulates Sequence-Specific TET2 Binding
Cancer Discovery Mar 2015, 5 (3) OF6; DOI: 10.1158/2159-8290.CD-RW2015-013
TET Monoubiquitylation by CRL4^VprBP Is Vital for Its DNA Binding
Cancer Discovery Feb 2015, 5 (2) 105; DOI: 10.1158/2159-8290.CD-RW2015-005
The H2A Ubiquitin Ligase TRIM37 Is a Breast Cancer Oncoprotein
Cancer Discovery Jan 2015, 5 (1) OF14; DOI: 10.1158/2159-8290.CD-RW2014-251
A Chemical Genetic Approach Engineers Selective BET Inhibitors
Cancer Discovery Dec 2014, 4 (12) OF11; DOI: 10.1158/2159-8290.CD-RW2014-222
Loss of PRC2 Function Promotes MPNST Pathogenesis
Cancer Discovery Nov 2014, 4 (11) OF14; DOI: 10.1158/2159-8290.CD-RW2014-206
PRC2 Subunits Are Tumor Suppressors in NF1-Deficient Solid Tumors
Cancer Discovery Oct 2014, 4 (10) 1114; DOI: 10.1158/2159-8290.CD-RW2014-180
Global Histone Acetylation Levels in Cancer Are Determined by AKT Activity
Cancer Discovery Sep 2014, 4 (9) 986; DOI: 10.1158/2159-8290.CD-RW2014-153
LncRNA-driven H4K20 Trimethylation Contributes to Quiescence
Cancer Discovery Jul 2014, 4 (7) OF10; DOI: 10.1158/2159-8290.CD-RW2014-101
The Putative Tumor Suppressor ZMYND11 Recognizes H3.3K36me3
Cancer Discovery May 2014, 4 (5) OF12; DOI: 10.1158/2159-8290.CD-RW2014-065

Main menu